{"id":62523,"date":"2026-01-21T16:06:13","date_gmt":"2026-01-21T15:06:13","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/distribution-centers-using-exoskeletons-cut-total-strain-and-sprain-injury-rate-by-62-new-long-term-data-shows\/"},"modified":"2026-01-21T16:06:13","modified_gmt":"2026-01-21T15:06:13","slug":"distribution-centers-using-exoskeletons-cut-total-strain-and-sprain-injury-rate-by-62-new-long-term-data-shows","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/distribution-centers-using-exoskeletons-cut-total-strain-and-sprain-injury-rate-by-62-new-long-term-data-shows\/","title":{"rendered":"Distribution Centers Using Exoskeletons Cut Total Strain and Sprain Injury Rate by 62%, New Long-Term Data Shows"},"content":{"rendered":"
\n

\nNew industry-first study found total strain and sprain injuries were reduced when warehouse workers across five sites wore back exosuits.<\/i><\/p>\n

NASHVILLE, Tenn.–(BUSINESS WIRE)–#exosuit<\/a>—HeroWear<\/a>, an occupational exoskeleton provider, has announced breakthrough longitudinal safety data from five distribution centers over 8 to 23 months and a combined 311,000 work hours, signifying a 62% reduction in total strain and sprain injuries among workers who wore the Apex 2 exosuit.<\/p>\n

<\/a>
<\/a>
<\/a>
<\/a><\/p>\n

\nHeroWear\u2019s flexible, back-assist exosuit functions like an extra set of back muscles to limit strain, fatigue, and discomfort. At each distribution center, the lightweight exosuit helped workers lift and carry thousands of pounds of goods during case-picking shifts.<\/p>\n

\nFears about potential unintended consequences\u2014like shifting injury risk from the back to other joints or muscle groups\u2014have long been a barrier to exoskeleton adoption. While previous <\/b>longitudinal data on occupational exoskeletons heavily focused on back strains, for the first time, multi-site industry data suggest that worker injury risk was not transferred to other body parts with this elastic back exosuit. Data from five companies with long-term, sustained exosuit use instead showed meaningful reductions in back injuries, with no corresponding rise in injuries elsewhere when comparing rates before and after deployment.<\/p>\n

\n\u201cEmerging technologies demand continuous learning, and the only way we advance is through converging, real-world evidence,\u201d said Dr. Karl Zelik, co-founder and chief scientific officer of HeroWear. \u201cI\u2019m deeply grateful to the companies willing to share this longitudinal data. They\u2019re accelerating progress for all of us and helping make every workplace safer.\u201d<\/p>\n

\nInjury outcomes were tracked among logistics workers in food and beverage, retail, manufacturing, and general warehousing sectors who wore exosuits for 8 and 23 months, encompassing over 311,000 hours of work \u2014 the equivalent of 155 full-time workers working over one year. Workers in these industries experience high rates of serious injury from overexertion, costing U.S. transportation and warehousing businesses $1.45 billion<\/a> in losses in 2025.<\/p>\n

\nThe long-term, aggregated data from the five companies revealed:<\/p>\n